Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with the potential for efficacy and safety, while greatly reducing R&D risk, time, and expense.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Concert Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Concert Pharmaceuticals Inc market cap is $401.95M.
What is the 52-week high for Concert Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Concert Pharmaceuticals Inc 52 week high is $8.55 as of September 15, 2025.
What is the 52-week low for Concert Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Concert Pharmaceuticals Inc 52 week low is $2.66 as of September 15, 2025.
What is Concert Pharmaceuticals Inc stock price today?
Concert Pharmaceuticals Inc stock price today is $8.39.
What was Concert Pharmaceuticals Inc stock price yesterday?
Concert Pharmaceuticals Inc stock price yesterday was $8.36.
What is the PE ratio of Concert Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Concert Pharmaceuticals Inc’s P/E ratio is -2.61.
What is the Price-to-Book ratio of Concert Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Concert Pharmaceuticals Inc P/B ratio is 3.0105.
What is the 50-day moving average of Concert Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Concert Pharmaceuticals Inc 50-day moving average is $7.57.
